نتایج جستجو برای: biomarker panel

تعداد نتایج: 139714  

Journal: :Obesity surgery 2011
Zobair M Younossi Sandra Page Nila Rafiq Aybike Birerdinc Maria Stepanova Noreen Hossain Arian Afendy Zahra Younoszai Zachary Goodman Ancha Baranova

BACKGROUND Patients with biopsy-proven NASH and especially those with fibrosis are at risk for progressive liver disease, emphasizing the clinical importance of developing non-invasive biomarkers for NASH and NASH-related fibrosis. AIM This study examines the performance of a new biomarker panel for NASH and NASH-related fibrosis with a combination of clinical and laboratory variables. METH...

Journal: :گوارش 0
elnaz naderimanesh soudabeh jahanbakhshkadehkahriz ashraf mohammadkhani

saliva is multifunctional; it is a lubricant for speech, aide for food digestion, and protective against microorganisms. it is voluntarily accessible, composed of proteins and electrolytes, and is ideal for the early detection of a wide range of diseases. because of a complex protein mixture, saliva proteomics has the potential to be a novel approach in the search for protein biomarkers. most s...

2011
Ping Yip Tzong-Hao Chen Partha Seshaiah Laurie L. Stephen Karri L. Michael-Ballard James P. Mapes Brian C. Mansfield Greg P. Bertenshaw

FDA-cleared ovarian cancer biomarkers are limited to CA-125 and HE4 for monitoring and recurrence and OVA1, a multivariate panel consisting of CA-125 and four additional biomarkers, for referring patients to a specialist. Due to relatively poor performance of these tests, more accurate and broadly applicable biomarkers are needed. We evaluated the dysregulation of 259 candidate cancer markers i...

Journal: :International journal of cancer 2010
Kenneth Wayne Marshall Steve Mohr Faysal El Khettabi Nadejda Nossova Samuel Chao Weisheng Bao Jun Ma Xiao-Jun Li Choong-Chin Liew

Colorectal cancer (CRC) is often curable and preventable using current screening modalities. Unfortunately, screening compliance remains low, partly due to patient dissatisfaction with faecal/endoscopic testing. Recent guidelines advise CRC screening should begin with risk stratification. A blood-based test providing clinically actionable CRC risk information would likely improve screening comp...

2014
Youwen Tan Tengli Pan Yun Ye Guohong Ge Li Chen Danfeng Wen Shengqiang Zou

BACKGROUND Circulating microRNAs (miRNAs), which are extremely stable and protected from RNAse-mediated degradation in body fluids, have emerged as candidate biomarkers for many diseases. The present study aimed to identify a serum microRNA (miRNA) expression profile that could serve as a novel diagnostic biomarker for primary biliary cirrhosis (PBC). METHODS Serum miRNA expression was invest...

2014
Janet L. Brandsma Malini Harigopal Nancy B. Kiviat Ying Sun Yanhong Deng Daniel Zelterman Paul M. Lizardi Veronika S. Shabanova Angelique Levi Tian Yaping Xinyuan Hu Qinghua Feng

An accurate biomarker for the follow-up of women positive for human papillomavirus type 16 (HPV16) DNAmay improve the efficiency of cervical cancer prevention. Previously, we analyzed all 113HPV16CpGs in cervical cytology samples and discovered differential methylation at different stages of premalignancy. In the current study, we identified amethylation biomarker consisting of a panel of 12HPV...

Journal: :Circulation 2006
Jean-Claude Tardif Therese Heinonen David Orloff Peter Libby

Cardiovascular biomarker research efforts have resulted in the identification of new risk factors and novel drug targets, as well as the establishment of treatment guidelines. Government agencies, academic research institutions, diagnostic industries, and pharmaceutical companies all recognize the importance of biomarkers in advancing therapies to improve public health. In drug development, bio...

2015
Adriana Albini Daniela Briga Matteo Conti Antonino Bruno Daniela Farioli Sara Canali Ilaria Sogno Gioacchino D'Ambrosio Paolo Consonni Douglas M. Noonan

RATIONALE Surface-Activated Chemical Ionization/Electrospray Ionization mass spectrometry (SACI/ESI-MS) is a technique with high sensitivity and low noise that allows accurate biomarker discovery studies. We developed a dedicated SACI/ESI software, named SANIST, for both biomarker fingerprint data acquisition and as a diagnostic tool, using prostate cancer (PCa) as the disease of interest. ME...

2014
Daniel G. Weber Swaantje Casjens Georg Johnen Oleksandr Bryk Irina Raiko Beate Pesch Jens Kollmeier Torsten T. Bauer Thomas Brüning

BACKGROUND For the detection of malignant mesothelioma no single biomarker with reasonable sensitivity and specificity has been described so far. Mesothelin, the most prominent blood-based biomarker, is characterized by high specificity but low sensitivity. It might be reasonable to combine biomarkers of different molecular classes in order to improve the overall performance. The aim of this st...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید